| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Metronidazole hydrochloride |
Is a |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole measurement |
Component |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole adverse reaction |
Causative agent (attribute) |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Allergy to metronidazole (finding) |
Causative agent (attribute) |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| métronidazole 5 mg/mL, flacon de 20 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| métronidazole 5 mg/mL, sac de 100 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 500 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 1 g rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole+nystatin 400mg/10000units tablet+pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole [vaginal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 7.5 mg/g vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing diloxanide and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole+antifungal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing metronidazole in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing metronidazole in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole-containing product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 750mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 5mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 0.75% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 100mg infusion solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole benzoate (substance) |
Is a |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing metronidazole and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth subsalicylate and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing cefuroxime and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole and tinidazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Allergy to metronidazole (finding) |
Causative agent (attribute) |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
3 |
| Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole benzoate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 750mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
|
| Metronidazole 500 mg rectal suppository |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 500 mg rectal suppository |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely diloxanide 250 milligram and metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
3 |
| Product containing diloxanide and metronidazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 375 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing metronidazole in dental dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing metronidazole in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole (as metronidazole benzoate) 40 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole (as metronidazole benzoate) 250 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 7.5 mg/g vaginal gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole 7.5 mg/g vaginal gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 500 milligram/100 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely metronidazole 500 milligram/100 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only cefuroxime and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only bismuth subsalicylate and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only diloxanide and metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Metronidazole and nystatin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
| Product containing only metronidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Metronidazole (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]